-

Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System

Expanding possibilities for pharmaceutical sample analysis

SANTA CLARA, Calif.,--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest addition to the Cary 3500 UV-Vis Series with the release of the Agilent Cary 3500 Flexible UV-Vis System. This new solution is a double-beam spectrophotometer with advanced photometric performance for diverse sample-type measurements with minimal sample preparation. The Cary 3500 UV-Vis Series can be deployed in regulated environments, specifically the pharma/biopharma industry.

The new Cary 3500 Flexible UV-Vis system offers a uniquely large sample compartment with a small footprint for analyzing a range of liquid samples and characterizing solid samples. The full Cary 3500 UV-Vis spectrophotometer series also includes a 10-year warranty xenon flash lamp, (for Cary 3500 instruments purchased from Agilent or participating partners), drastically reducing the frequency and cost of deuterium lamp replacement, and eliminating the daily warmup time.

Another key development is the enhancement of the Cary UV Workstation software. New calculations can now be saved and applied automatically to any method routinely used to reduce data processing time and calculation errors. It is accessible to new customers and existing users who want to upgrade to the latest software version. Additionally, the Cary 3500 UV-Vis spectrophotometer series, including the new UV-Vis Flexible module, can be deployed with the OpenLab software suite to help organizations achieve their data management and compliance goals.

“The Cary 3500 Flexible UV-Vis spectrophotometer is the next major step in a long history of UV-Vis innovation at Agilent,” said Geoff Winkett, vice president and general manager of Agilent’s Molecular Spectroscopy Division.

Winkett continued. “The series has been an incredible success since its introduction in 2018 and our customers—particularly those in the pharma and biopharma industries—have benefitted from the unique range of capabilities. This further strengthens our distinctive portfolio of integrated solutions under the Agilent OpenLab umbrella, from chromatography to mass spectroscopy, to UV-Vis spectroscopy.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to...

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...
Back to Newsroom